Business Description
Sigyn Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US75932R1059
Share Class Description:
SIGY: Ordinary SharesDescription
Sigyn Therapeutics Inc is a development-stage therapeutic technology company. Its business focus is the clinical advancement of Sigyn Therapy, a multi-function blood purification technology designed to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths world-wide. To support widespread implementation, the company designed Sigyn Therapy to be a single-use disposable device that is deployable on the world-wide infrastructure of hemodialysis and continuous renal replacement therapy machines already located in hospitals and clinics.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -10.6 | |||||
| Debt-to-Equity | -0.7 | |||||
| Debt-to-EBITDA | -1.15 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 27.1 | |||||
| 3-Year EPS without NRI Growth Rate | 15.6 | |||||
| 3-Year FCF Growth Rate | 35 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.78 | |||||
| 9-Day RSI | 29.33 | |||||
| 14-Day RSI | 36.46 | |||||
| 6-1 Month Momentum % | -8.33 | |||||
| 12-1 Month Momentum % | -8.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.03 | |||||
| Quick Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.5 | |||||
| Shareholder Yield % | -20.43 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -1004.36 | |||||
| ROIC % | -91.9 | |||||
| ROC (Joel Greenblatt) % | -991.04 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -4.05 | |||||
| EV-to-EBITDA | -4.06 | |||||
| EV-to-FCF | -6.37 | |||||
| Earnings Yield (Greenblatt) % | -24.69 | |||||
| FCF Yield % | -22.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SIGY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Sigyn Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.77 | ||
| Beta | -0.98 | ||
| Volatility % | 160.17 | ||
| 14-Day RSI | 36.46 | ||
| 14-Day ATR ($) | 0.134385 | ||
| 20-Day SMA ($) | 5.624 | ||
| 12-1 Month Momentum % | -8.84 | ||
| 52-Week Range ($) | 2.08 - 12.8 | ||
| Shares Outstanding (Mil) | 1.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sigyn Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sigyn Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sigyn Therapeutics Inc Frequently Asked Questions
What is Sigyn Therapeutics Inc(SIGY)'s stock price today?
The current price of SIGY is $5.00. The 52 week high of SIGY is $12.80 and 52 week low is $2.08.
When is next earnings date of Sigyn Therapeutics Inc(SIGY)?
The next earnings date of Sigyn Therapeutics Inc(SIGY) is 2024-05-16 Est..
Does Sigyn Therapeutics Inc(SIGY) pay dividends? If so, how much?
Sigyn Therapeutics Inc(SIGY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers